【Lotus Pharmaceutical】Announcement of the Board of Directors' Resolution to Approve the 2026 First Quarter Financial Report
NQ Score
0/100
N1 Content Completeness
90
AI Summary (NQ-processed)
Lotus Pharmaceutical's Board of Directors has approved the financial report for the first quarter of 2026. The report shows revenue of NT$8,644,409 thousand, net profit of NT$567,201 thousand, and EPS of NT$2.18.